SEGLUROMET 500 mg/1

SEGLUROMET 500 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a comprehensive treatment plan.

SEGLUROMET 500 mg/1 is typically used to improve glycemic control in adults with type 2 diabetes. It works by helping the body respond better to insulin and reducing sugar absorption in the intestines. This medication is often part of a broader diabetes management strategy, which may include diet and exercise.

Common effects of SEGLUROMET 500 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may experience urinary tract infections or low blood sugar, especially when combined with other diabetes medications. These effects can vary and are not experienced by everyone.

SEGLUROMET 500 mg/1 should be handled with care, especially for those with kidney issues or a history of pancreatitis. It is important to follow medical advice regarding its use, particularly if you have other health conditions or are taking other medications. Always store this medication as directed.

SEGLUROMET 500 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of low blood sugar. Always consult a healthcare provider before starting any new medication.